The safety of air transportation of patients with advanced lung disease: Experience with 21 patients requiring lung transplantation or pulmonary thromboendarterectomy

M. R. Kramer, D. J. Jakobson, C. Springer, Y. Donchin

Research output: Contribution to journalArticlepeer-review

Abstract

Air travel can cause severe respiratory decompensation in a patient with advanced lung disease due to high altitude hypoxemia. We report our experience in flying 21 patients with advanced lung disease to a medical center remote from Israel for lung transplantation or pulmonary thromboendarterectomy (PTE). All patients had severe lung disease with marked hypoxemia (PaO2, 40 to 59) and 16 had significant pulmonary hypertension. Nine patients (with emphysema and pulmonary fibrosis) required single lung transplant, four (with cystic fibrosis and emphysema) required double-lung transplant, six (with primary or secondary pulmonary hypertension) required heart-lung transplant, and two (with major vessel pulmonary thrombosis) required PTE. All patients were flown by commercial aircraft to centers located 2,634 to 13,181 km away from Israel. Length of flight was between 4 and 21 h. Patients were given oxygen supplementation during the flight and were monitored by portable oximeters. All but three patients were hemodynamically stable and 19 of them were escorted by physicians. All but one hemodynamically unstable patient who died on board arrived safely at their destinations. We conclude that with careful preparation, sufficient oxygen supply, oximetric monitoring, and medical escort, almost any patient with severe lung disease can travel by air to any necessary destination.

Original languageEnglish
Pages (from-to)1292-1296
Number of pages5
JournalChest
Volume108
Issue number5
DOIs
StatePublished - 1995
Externally publishedYes

Keywords

  • air transport
  • COPD
  • emphysema
  • high altitude
  • hypoxemia
  • lung transplantation

Fingerprint

Dive into the research topics of 'The safety of air transportation of patients with advanced lung disease: Experience with 21 patients requiring lung transplantation or pulmonary thromboendarterectomy'. Together they form a unique fingerprint.

Cite this